Drug Trial Radar · NCT06267560
Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD
Last checked: Nov 19, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
422
Actual
Start
Apr 24, 2024
Primary completion
Mar 25, 2026
Study completion Mar 25, 2026
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Feb 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study CTQJ230A12303 is a randomized, double-blind placebo-controlled, Phase IIIb study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) 80 mg s.c. QM compared with placebo s.c. QM in US Black/African American and Hispanic participants with established ASCVD and elevated levels of Lp(a) who are treated for cardiovascular (CV) risk factors according to local practice/guidelines for the reduction of cardiovascular risk.
Conditions
- Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
Interventions
TQJ230Drug
TQJ230 80mg QM s.c.
PlaceboDrug
matching placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in log-transformed Lp(a) concentration from baseline at week 52Time frame: Baseline, week 52
Locations
96 sites in 2 countries. Site status is shown where the registry gives one.
Parkway Medical Center
Birmingham, Alabama
Cardiology and Medicine Clinic PA
Little Rock, Arkansas
National Heart Institute
Beverly Hills, California
Alliance Clinical
Canoga Park, California
Valley Clinical Trials Inc
Covina, California
NICRs Research Center
Garden Grove, California
University of Calif Irvine Med Cntr
Irvine, California
Long Beach Clinical Trials
Long Beach, California
Angel City Research Inc
Los Angeles, California
California Medical Research Associates Inc
Northridge, California
Stanford University Medical Center
Palo Alto, California
Acclaim Clinical Research
San Diego, California
Excel Medical Clinical Trials LLC
Boca Raton, Florida
C and A Clinical Trials
Cape Coral, Florida
Proactive Clinical Research
Fort Lauderdale, Florida
National Research Institute
Hialeah, Florida
Sister Life Research Inc
Hialeah, Florida
Zenith Clinical Research
Hollywood, Florida
Columbus Clinical Services LLC
Miami, Florida
Finlay Medical Research
Miami, Florida
Infinite Clinical Research
Miami, Florida
Flourish Research Miami LLC
Miami, Florida
International Research Associates LLC
Miami, Florida
Baptist Health South
Miami, Florida
A&A Research Group Inc
Miami, Florida
Inpatient Research Clinical LLC
Miami Lakes, Florida
FXM Clin Res Miramar LLC
Miramar, Florida
CTMD Research
Palm Springs, Florida
DBC Research USA
Pembroke Pines, Florida
New Tampa Health
Tampa, Florida
James A Haley Veterans Hospital
Tampa, Florida
Cardiology Partners Clinical Research Institute
Wellington, Florida
Flourish Research
Winter Park, Florida
Morehouse School Of Medicine
Atlanta, Georgia
Atlanta Heart Specialists LLC
Tucker, Georgia
Synexus Clinical Research US Inc
Chicago, Illinois
Chicago Clinical Research Inst
Chicago, Illinois
Cardiovascular Associates Research
Covington, Louisiana
Omega Clinical Research
Metairie, Louisiana
CV Ins of the South
Opelousas, Louisiana
Showing 40 of 96 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.